![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 14, 8683-8685, May, 1991
JD Sandy, PJ Neame, RE Boynton and CR Flannery
Shriners Hospital for Crippled Children, Tampa Unit, Florida 33612.
The catabolism of aggrecan has been studied in calf articular cartilage explant cultures. The chondroitin sulfate-rich, high buoyant density products that accumulate in culture medium have been purified, and NH2- terminal sequence data have been obtained. Aggrecan released from the tissue in the presence or absence of interleukin-1 alpha, whether analyzed before or after reduction and alkylation, exhibited only one major and one minor NH2-terminal sequence. The major sequence, ARGXVILXAKPDF, shows very high similarity to a region of the interglobular domain (between the G1 and G2 domains) of both human and rat aggrecan. The minor sequence, VEVS, was that previously described for the NH2 terminus of the intact core protein. These results indicate that catabolism of aggrecan in cartilage explants involves proteolytic cleavage within a conserved region of the interglobular domain and that this results in the separation of the G1 domain from the remainder of the molecule. A major product of this process is a large nonaggregating species that consists of an NH2-terminal sequence beginning with ARG (and composed of about 100 residues of the interglobular domain) that is attached to an intact G2 domain followed by an extended section of the chondroitin sulfate-bearing domain toward the COOH terminus.
This article has been cited by other articles:
![]() |
K Tahiri, C Korwin-Zmijowska, P Richette, F Heraud, X Chevalier, J-F Savouret, and M-T Corvol Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease adamts-5 expression in interleukin 1{beta}-treated chondrocytes Ann Rheum Dis, May 1, 2008; 67(5): 696 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fushimi, L. Troeberg, H. Nakamura, N. H. Lim, and H. Nagase Functional Differences of the Catalytic and Non-catalytic Domains in Human ADAMTS-4 and ADAMTS-5 in Aggrecanolytic Activity J. Biol. Chem., March 14, 2008; 283(11): 6706 - 6716. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Ilic, C. J. East, F. M. Rogerson, A. J. Fosang, and C. J. Handley Distinguishing Aggrecan Loss from Aggrecan Proteolysis in ADAMTS-4 and ADAMTS-5 Single and Double Deficient Mice J. Biol. Chem., December 28, 2007; 282(52): 37420 - 37428. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gendron, M. Kashiwagi, N. H. Lim, J. J. Enghild, I. B. Thogersen, C. Hughes, B. Caterson, and H. Nagase Proteolytic Activities of Human ADAMTS-5: COMPARATIVE STUDIES WITH ADAMTS-4 J. Biol. Chem., June 22, 2007; 282(25): 18294 - 18306. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. East, H. Stanton, S. B. Golub, F. M. Rogerson, and A. J. Fosang ADAMTS-5 Deficiency Does Not Block Aggrecanolysis at Preferred Cleavage Sites in the Chondroitin Sulfate-rich Region of Aggrecan J. Biol. Chem., March 23, 2007; 282(12): 8632 - 8640. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Poon, A. H. Plaas, D. R. Keene, D. J. McQuillan, K. Last, and A. J. Fosang N-Linked Keratan Sulfate in the Aggrecan Interglobular Domain Potentiates Aggrecanase Activity J. Biol. Chem., June 24, 2005; 280(25): 23615 - 23621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mahmoodi, S. Sahebjam, D. Smookler, R. Khokha, and J. S. Mort Lack of Tissue Inhibitor of Metalloproteinases-3 Results in an Enhanced Inflammatory Response in Antigen-Induced Arthritis Am. J. Pathol., June 1, 2005; 166(6): 1733 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Wight The ADAMTS Proteases, Extracellular Matrix, and Vascular Disease: Waking the Sleeping Giant(s)! Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 12 - 14. [Full Text] [PDF] |
||||
![]() |
G. Gao, A. Plaas, V. P. Thompson, S. Jin, F. Zuo, and J. D. Sandy ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1 J. Biol. Chem., March 12, 2004; 279(11): 10042 - 10051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kashiwagi, J. J. Enghild, C. Gendron, C. Hughes, B. Caterson, Y. Itoh, and H. Nagase Altered Proteolytic Activities of ADAMTS-4 Expressed by C-terminal Processing J. Biol. Chem., March 12, 2004; 279(11): 10109 - 10119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Heathfield, P. Onnerfjord, L. Dahlberg, and D. Heinegard Cleavage of Fibromodulin in Cartilage Explants Involves Removal of the N-terminal Tyrosine Sulfate-rich Region by Proteolysis at a Site That Is Sensitive to Matrix Metalloproteinase-13 J. Biol. Chem., February 20, 2004; 279(8): 6286 - 6295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Makihira, W. Yan, H. Murakami, M. Furukawa, T. Kawai, H. Nikawa, E. Yoshida, T. Hamada, Y. Okada, and Y. Kato Thyroid Hormone Enhances Aggrecanase-2/ADAM-TS5 Expression and Proteoglycan Degradation in Growth Plate Cartilage Endocrinology, June 1, 2003; 144(6): 2480 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yasumoto, J. L. E. Bird, K. Sugimoto, R. M. Mason, and M. T. Bayliss The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein Rheumatology, February 1, 2003; 42(2): 336 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Malfait, R.-Q. Liu, K. Ijiri, S. Komiya, and M. D. Tortorella Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage J. Biol. Chem., June 14, 2002; 277(25): 22201 - 22208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Westling, A. J. Fosang, K. Last, V. P. Thompson, K. N. Tomkinson, T. Hebert, T. McDonagh, L. A. Collins-Racie, E. R. LaVallie, E. A. Morris, et al. ADAMTS4 Cleaves at the Aggrecanase Site (Glu373-Ala374) and Secondarily at the Matrix Metalloproteinase Site (Asn341-Phe342) in the Aggrecan Interglobular Domain J. Biol. Chem., May 3, 2002; 277(18): 16059 - 16066. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Bandtlow and D. R. Zimmermann Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins Physiol Rev, October 1, 2000; 80(4): 1267 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Curtis, C. E. Hughes, C. R. Flannery, C. B. Little, J. L. Harwood, and B. Caterson n-3 Fatty Acids Specifically Modulate Catabolic Factors Involved in Articular Cartilage Degradation J. Biol. Chem., January 14, 2000; 275(2): 721 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Meurs, P. van Lent, A. Holthuysen, D. Lambrou, E. Bayne, I. Singer, and W. van den Berg Active Matrix Metalloproteinases Are Present in Cartilage During Immune Complex-Mediated Arthritis: A Pivotal Role for Stromelysin-1 in Cartilage Destruction J. Immunol., November 15, 1999; 163(10): 5633 - 5639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Mercuri, K. J. Doege, E. C. Arner, M. A. Pratta, K. Last, and A. J. Fosang Recombinant Human Aggrecan G1-G2 Exhibits Native Binding Properties and Substrate Specificity for Matrix Metalloproteinases and Aggrecanase J. Biol. Chem., November 5, 1999; 274(45): 32387 - 32395. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Abbaszade, R.-Q. Liu, F. Yang, S. A. Rosenfeld, O. H. Ross, J. R. Link, D. M. Ellis, M. D. Tortorella, M. A. Pratta, J. M. Hollis, et al. Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family J. Biol. Chem., August 13, 1999; 274(33): 23443 - 23450. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. ARNER, M. A. PRATTA, C. P. DECICCO, C.-B. XUE, R. C. NEWTON, J. M. TRZASKOS, R. L. MAGOLDA, and M. D. TORTERELLA Aggrecanase: A Target for the Design of Inhibitors of Cartilage Degradation Ann. N.Y. Acad. Sci., June 30, 1999; 878(1): 92 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Tortorella, T. C. Burn, M. A. Pratta, I. Abbaszade, J. M. Hollis, R. Liu, S. A. Rosenfeld, R. A. Copeland, C. P. Decicco, R. Wynn, et al. Purification and Cloning of Aggrecanase-1: A Member of the ADAMTS Family of Proteins Science, June 4, 1999; 284(5420): 1664 - 1666. [Abstract] [Full Text] |
||||
![]() |
J B J van Meurs, P L E M van Lent, A A J van de Loo, A E M Holthuysen, E K Bayne, I I Singer, and W B van den Berg Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis Ann Rheum Dis, June 1, 1999; 58(6): 350 - 356. [Abstract] [Full Text] |
||||
![]() |
E. C. Arner, M. A. Pratta, J. M. Trzaskos, C. P. Decicco, and M. D. Tortorella Generation and Characterization of Aggrecanase. A SOLUBLE, CARTILAGE-DERIVED AGGRECAN-DEGRADING ACTIVITY J. Biol. Chem., March 5, 1999; 274(10): 6594 - 6601. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hughes, C. B. Little, F. H. Buttner, E. Bartnik, and B. Caterson Differential Expression of Aggrecanase and Matrix Metalloproteinase Activity in Chondrocytes Isolated from Bovine and Porcine Articular Cartilage J. Biol. Chem., November 13, 1998; 273(46): 30576 - 30582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Ilic, H. C. Robinson, and C. J. Handley Characterization of Aggrecan Retained and Lost from the Extracellular Matrix of Articular Cartilage. INVOLVEMENT OF CARBOXYL-TERMINAL PROCESSING IN THE CATABOLISM OF AGGRECAN J. Biol. Chem., July 10, 1998; 273(28): 17451 - 17458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hughes, F. H. Buttner, B. Eidenmuller, B. Caterson, and E. Bartnik Utilization of a Recombinant Substrate rAgg1 to Study the Biochemical Properties of Aggrecanase in Cell Culture Systems J. Biol. Chem., August 8, 1997; 272(32): 20269 - 20274. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Arner, C. P. Decicco, R. Cherney, and M. D. Tortorella Cleavage of Native Cartilage Aggrecan by Neutrophil Collagenase (MMP-8) Is Distinct from Endogenous Cleavage by Aggrecanase J. Biol. Chem., April 4, 1997; 272(14): 9294 - 9299. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Barry, L. C. Rosenberg, J. U. Gaw, J. U. Gaw, T. J. Koob, and P. J. Neame N- and O-Linked Keratan Sulfate on the Hyaluronan Binding Region of Aggrecan from Mature and Immature Bovine Cartilage J. Biol. Chem., September 1, 1995; 270(35): 20516 - 20524. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Lark, J. T. Gordy, J. R. Weidner, J. Ayala, J. H. Kimura, H. R. Williams, R. A. Mumford, C. R. Flannery, S. S. Carlson, M. Iwata, et al. Cell-mediated Catabolism of Aggrecan J. Biol. Chem., February 10, 1995; 270(6): 2550 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pratta, M. D. Tortorella, and E. C. Arner Age-related Changes in Aggrecan Glycosylation Affect Cleavage by Aggrecanase J. Biol. Chem., December 8, 2000; 275(50): 39096 - 39102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Tortorella, M. Pratta, R.-Q. Liu, J. Austin, O. H. Ross, I. Abbaszade, T. Burn, and E. Arner Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4) J. Biol. Chem., June 9, 2000; 275(24): 18566 - 18573. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Mercuri, R. A. Maciewicz, J. Tart, K. Last, and A. J. Fosang Mutations in the Interglobular Domain of Aggrecan Alter Matrix Metalloproteinase and Aggrecanase Cleavage Patterns. EVIDENCE THAT MATRIX METALLOPROTEINASE CLEAVAGE INTERFERES WITH AGGRECANASE ACTIVITY J. Biol. Chem., October 13, 2000; 275(42): 33038 - 33045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |